Skip to the page

Data / Drug companies / Proximity Capital Partners LLC DBA Asutra

Proximity Capital Partners LLC DBA Asutra: 10 products in the FDA NDC directory, labeler code 72683

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Proximity Capital Partners LLC DBA Asutra (labeler code 72683) lists 10 products in the FDA National Drug Code Directory, covering 3 finished drugs by generic name. By type: 10 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on June 17, 2026.

The request: Watch Proximity Capital Partners LLC DBA Asutra (FDA labeler code 72683): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
72683
Products in commercial distribution
10
Packages
12
Finished drugs by generic name
3
Prescription products
0
Over the counter products
10
Flagged as original packager
10 of 10 products that carry the flag
Started marketing in the last 12 months
4
Earliest marketing start
January 21, 2019
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Over the counter monograph drugs990%
Unapproved homeopathic products110%

Products by type

TypeProductsShare
Over the counter drugs10100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Capsaicin666
Menthol2263
Menthol, camphor120

Dosage forms

Dosage formProductsShare
Cream440%
Gel440%
Spray220%

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
SprayPain Away Lavender72683-012SprayOver the counter monograph drugsJune 17, 2026
Roll Pain Away Lemongrass72683-011GelOver the counter monograph drugsJune 17, 2026
Roll Pain Away Lavender72683-010GelOver the counter monograph drugsJune 17, 2026
Roll Pain Away72683-009GelOver the counter monograph drugsJune 17, 2026
Recovery Roll-On72683-008GelOver the counter monograph drugsOctober 17, 2022
SprayPain Away72683-006SprayOver the counter monograph drugsJune 30, 2021
Relieve Your Pain72683-005CreamOver the counter monograph drugsApril 29, 2021
Melt Pain Away72683-003CreamOver the counter monograph drugsApril 15, 2020
WellHeal72683-001CreamUnapproved homeopathic productsMarch 18, 2019
Ease Your Pain72683-002CreamOver the counter monograph drugsJanuary 21, 2019

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.